{"title":"新产品介绍[ADV-7103(新组合),菊Erwinia,恩格列净(新适应症),MVC-COV-1901, ON-101,彭普利单抗,ponesimod, sotorasib, upacicalcet sodium hydrate, upadacitinib酒石酸盐(新适应症),zimberelimab, ZyCoV-D]","authors":"","doi":"10.1358/dot.2021.57.11.3381582","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":85144,"journal":{"name":"Medicamentos de actualidad. Drugs of today","volume":"50 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"New product intros [ADV-7103 (new combination), asparaginase Erwinia chrysanthemi, empagliflozin (new indication), MVC-COV-1901, ON-101, penpulimab, ponesimod, sotorasib, upacicalcet sodium hydrate, upadacitinib tartrate (new indication), zimberelimab, ZyCoV-D]\",\"authors\":\"\",\"doi\":\"10.1358/dot.2021.57.11.3381582\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":85144,\"journal\":{\"name\":\"Medicamentos de actualidad. Drugs of today\",\"volume\":\"50 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicamentos de actualidad. Drugs of today\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1358/dot.2021.57.11.3381582\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicamentos de actualidad. Drugs of today","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1358/dot.2021.57.11.3381582","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
New product intros [ADV-7103 (new combination), asparaginase Erwinia chrysanthemi, empagliflozin (new indication), MVC-COV-1901, ON-101, penpulimab, ponesimod, sotorasib, upacicalcet sodium hydrate, upadacitinib tartrate (new indication), zimberelimab, ZyCoV-D]